Leveraging Infrastructure Investments & Innovation to Accelerate Biologics Development

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
With a growing pipeline of both traditional and regenerative biopharmaceutical drugs and increasing cadence of approvals for novel biologics and biosimilars, there is a need now more than ever for readily available solutions that will translate the promise of a remarkable discovery into a successful therapy. This webinar will showcase how Thermo Fisher Scientific is leveraging infrastructure investments and innovation to deliver platform and bespoke solutions meant to accelerate biologics development.

Speaker - Paul Jorjorian, Vice President / General Manager – Biologics, Thermo Fisher Scientific
Sponsored By